| Insulin Delivery Systems
Insulin Delivery Systems

Control-IQ Technology in the Real World: The First 30 Days

book_2 Source: ADA 2020 - Poster session
calendar_today Published on Medfyle: July 2020
headphones 1 min

This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.

Key messages

  • The t:slim X2 insulin pump with Control-IQ technology from Tandem Diabetes Care, Inc. was cleared by the Food and Drug Administration in December 2019. 
  • This was a retrospective analysis of users who uploaded at least 30 days of pre and 30 days of post Control-IQ software update usage data
  • The Control-IQ software update led to a 10% increase (p<0.001) of median sensor time in range (70-180 mg/dL) to 78% due to a 10% decrease in sensor time >180mg/dL to 21% and a 0.1% decrease of sensor time <70 mg/dL to 1.1%.
Presenting Author
Read more arrow_downward Hide arrow_upward

Lars Mueller, PhD
UC San Diego Design Lab Center for Health | Tandem Diabetes Care

Read more arrow_downward Hide arrow_upward

L. Mueller: Research Support; Self; Dexcom, Inc., Tandem Diabetes Care.